NCT06330805 - Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 12, 2024

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions

Prostate AdenocarcinomaStage IIB Prostate Cancer AJCC v8Stage IIC Prostate Cancer AJCC v8

Interventions

PROCEDURE

Biospecimen Collection

Undergo blood and urine sample collection

OTHER

Contrast Agent

Given IV

DRUG

Leuprolide

Given injection

PROCEDURE

Magnetic Resonance Imaging

Undergo MRI

OTHER

Physical Performance Testing

Undergo functional fitness tests

DRUG

Relugolix

Given PO

Trial Locations (1)

RECRUITING

Ohio State University Comprehensive Cancer Center, Columbus